Gene transfer-mediated intracellular photodynamic therapy
Abstract
The main limitation of photodynamic therapy is a very short penetrance length of the light in tissues. To overcome this shortcoming, a new method is proposed, where first a gene encoding protein luciferase is delivered using, e.g. adenovirus vector to the neoplastic cells and, after its expression, the photosensitizer, which should be activated, together with luciferin are injected to the organism. After their accumulation in the cancer cells, the photosensitizer activation is accomplished via light produced by chemiluminiscent reaction of luciferase and luciferin.
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S0306-9877(99)90012-9
doi:10.1054/mehy.1999.0012
© 2000 Harcourt Publishers Ltd. All rights reserved.
